Nyxoah SA
NYXH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001857190
No open-market purchases or sales by Nyxoah SA insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $37.5M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Nyxoah SA as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −2 vs. Q3 2022
- Shares held
- 2.65M
- −213.8K (−7.5%) vs. Q3 2022
- Total value
- $13.3M
- −$4.78M (−26.5%) vs. Q3 2022
- New holders
- 3
- 4 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NYXH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $37.5M |
| Q1 2026 | 34 | $10.4M |
| Q4 2025 | 33 | $16.8M |
| Q3 2025 | 32 | $13.5M |
| Q2 2025 | 31 | $29.2M |
| Q1 2025 | 26 | $41.8M |
| Q4 2024 | 22 | $54.4M |
| Q3 2024 | 20 | $39.1M |
| Q2 2024 | 21 | $29.4M |
| Q1 2024 | 19 | $29.3M |
| Q4 2023 | 16 | $9.76M |
| Q3 2023 | 17 | $18.2M |
| Q2 2023 | 16 | $21.1M |
| Q1 2023 | 18 | $17.6M |
| Q4 2022 | 18 | $13.3M |
| Q3 2022 | 20 | $18.1M |
| Q2 2022 | 22 | $28.1M |
| Q1 2022 | 18 | $59.1M |
| Q4 2021 | 16 | $60.9M |
| Q3 2021 | 18 | $75.1M |
| Q2 2021 | 1 | $5.75M |
| Q1 2021 | 1 | $7.18M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Nyxoah SA; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 653,319 | $3.26M | 0.00% | −2280.0% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 455,262 | $2.27M | 0.05% | 00.0% | Unchanged |
| Invesco Ltd. | 370,980 | $1.85M | 0.00% | −10,549−2.8% | Reduced |
| RTW Investments, LP | 269,993 | $1.35M | 0.03% | −74,918−21.7% | Reduced |
| AXA S.A. | 214,000 | $1.07M | 0.00% | +14,000+7.0% | Added |
| Putnam Investments LLC | 192,942 | $918.4K | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 149,131 | $801.4K | 0.13% | −72,818−32.8% | Reduced |
| Rossmore Private Capital | 117,940 | $646.9K | 0.10% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 108,172 | $539.8K | 0.00% | +57,790+114.7% | Added |
| Evolutionary Tree Capital Management, LLC | 54,345 | $271.5K | 0.26% | 00.0% | Unchanged |
| DekaBank Deutsche Girozentrale | 33,200 | $179.0K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 16,110 | $80.4K | 0.04% | 00.0% | Unchanged |
| Millennium Management LLC | 10,776 | $51.0K | 0.00% | +10,776 | New |
| Optiver Holding B.V. | 678 | $4.00K | 0.00% | +678 | New |
| Citigroup Inc | 631 | $3.46K | 0.00% | +219+53.2% | Added |
| UBS Group AG | 208 | $1.04K | 0.00% | +144+225.0% | Added |
| Wells Fargo & Company | 17 | $93 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 1 | $5 | 0.00% | +1 | New |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −79,021−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −29,472−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |